The mitochondrial uncoupler 2,4-dinitrophenol modulates inflammatory and oxidative responses in Trypanosoma

José Edson Caetano-da-Silva1, Elda Gonçalves-Santos2, Elisa L B C Domingues2

  • 1Programa de Pós-Graduação em Ciências Biológicas, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.

Insights

2,4-dinitrophenol (DNP) worsened Chagas disease myocarditis by suppressing protective inflammation, while benznidazole (Bz) offered cardioprotection. DNP

Area of Science:

  • Cardiovascular Research
  • Infectious Diseases
  • Pharmacology

Background:

  • Chagas disease, caused by Trypanosoma cruzi, leads to infectious myocarditis.
  • Reactive oxygen species (ROS) exacerbate myocarditis.
  • 2,4-dinitrophenol (DNP) uncouples oxidative phosphorylation, reducing ROS.

Purpose of the Study:

  • To investigate the impact of DNP-based chemotherapy on Trypanosoma cruzi-induced acute myocarditis.
  • To compare DNP's efficacy against benznidazole (Bz), a reference drug.

Main Methods:

  • C56BL/6 mice were infected with T. cruzi.
  • Mice received daily treatments of benznidazole (Bz) or DNP for 11 days.
  • Cardiac tissues were analyzed for microstructural, immunological, and biochemical changes.

Main Results:

  • DNP treatment aggravated heart infection and microstructural damage, despite reducing oxidative stress markers.
  • Benznidazole (Bz) markedly attenuated heart infection and cardiac damage.
  • DNP demonstrated antioxidant and anti-inflammatory effects, potentially favoring parasite survival.

Conclusions:

  • DNP exacerbated T. cruzi-induced myocarditis by suppressing host defense mechanisms.
  • Bz provided cardioprotection through combined anti-inflammatory and antiparasitic effects.
  • DNP's utility in Chagas disease myocarditis requires further investigation due to its detrimental impact on infection.